Abstract | BACKGROUND: METHODS: Eighteen AN subjects who engaged in open treatment with olanzapine were retrospectively questioned about their response. RESULTS: Subjects reported a significant reduction in anxiety, difficulty eating, and core eating disorder symptoms after taking olanzapine. DISCUSSION: These data lend support to the possibility that olanzapine may be useful in AN patients. CONCLUSION: A controlled trial is necessary to prove that olanzapine is efficacious.
|
Authors | Amanda Malina, Jill Gaskill, Claire McConaha, Guido K Frank, Maria LaVia, Lisa Scholar, Walter H Kaye |
Journal | The International journal of eating disorders
(Int J Eat Disord)
Vol. 33
Issue 2
Pg. 234-7
(Mar 2003)
ISSN: 0276-3478 [Print] United States |
PMID | 12616591
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2003 by Wiley Periodicals, Inc. |
Chemical References |
- Serotonin Uptake Inhibitors
- Benzodiazepines
- Pirenzepine
- Olanzapine
|
Topics |
- Adolescent
- Adult
- Anorexia Nervosa
(diagnosis, drug therapy)
- Benzodiazepines
- Humans
- Olanzapine
- Pirenzepine
(analogs & derivatives, therapeutic use)
- Retrospective Studies
- Selective Serotonin Reuptake Inhibitors
(therapeutic use)
- Surveys and Questionnaires
|